Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-07 Mills Kenneth T. President and CEO Option exercise +1,500 $0.85 $1K 283,484
2021-01-07 Mills Kenneth T. President and CEO Sale −1,500 $50.01 $75K 281,984
2021-01-07 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −1,500 47,670
2021-01-04 Vasista Vittal Chief Financial Officer Grant or award +12,400 145,424
2021-01-04 Vasista Vittal Chief Financial Officer Grant or award · Stock Option (Right to Buy) +56,200 56,200
2021-01-04 Simpson Curran Chief Oper. & Tech. Officer Grant or award +13,800 17,748
2021-01-04 Simpson Curran Chief Oper. & Tech. Officer Grant or award · Stock Option (Right to Buy) +62,300 62,300
2021-01-04 PAKOLA STEVE Chief Medical Officer Grant or award +11,000 11,000
2021-01-04 PAKOLA STEVE Chief Medical Officer Grant or award · Stock Option (Right to Buy) +49,700 49,700
2021-01-04 Danos Olivier Chief Scientific Officer Grant or award +11,600 19,043
2021-01-04 Danos Olivier Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +52,500 52,500
2021-01-04 Christmas Patrick J. Chief Legal Officer Grant or award +13,800 16,372
2021-01-04 Christmas Patrick J. Chief Legal Officer Grant or award · Stock Option (Right to Buy) +62,500 62,500
2021-01-04 Mills Kenneth T. President and CEO Grant or award +40,984 281,984
2021-01-04 Mills Kenneth T. President and CEO Grant or award · Stock Option (Right to Buy) +185,167 185,167
2020-12-28 Mills Kenneth T. President and CEO Option exercise +6,500 $0.85 $6K 247,500
2020-12-28 Mills Kenneth T. President and CEO Sale −4,647 $48.47 $225K 242,853
2020-12-28 Mills Kenneth T. President and CEO Sale −1,853 $49.16 $91K 241,000
2020-12-28 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −6,500 49,170
2020-12-24 Vasista Vittal Chief Financial Officer Sale −3,376 $50.00 $169K 133,024

Page 20 of 25 · 494 trades